Evidence map›Paper›PMID 34735461›Full record

ArticlePloS one2021

The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study.

Meghan M Moran, Peter Wessman, Ola Rolfson, Daniel D Bohl, Johan Kärrholm, Ali Keshavarzian, D Rick Sumner

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06951477 (Gut Microbiome in Orthopaedics), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06951477 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Gut Microbiome in Orthopaedics: Investigating the Role of Gut Microbiome Composition in Total Knee Arthroplasty Failure

TypeobservationalSponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sRan2025 to 2027Enrolled30ConditionsRevision Total Knee Arthroplasty, Osteoarthritis, KneeArmsRevision Total Knee Arthroplasty
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Meghan M MoranDepartment of Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL, United States of America.ORCID 0000-0001-7801-4849
Peter WessmanDepartment of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ola RolfsonDepartment of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Daniel D BohlDepartment of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, United States of America.ORCID 0000-0002-7599-4244
Johan KärrholmDepartment of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ali KeshavarzianDivision of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush Medical College, Chicago, IL, United States of America.ORCID 0000-0002-7969-3369
D Rick SumnerDepartment of Cell & Molecular Medicine, Rush University Medical Center, Chicago, IL, United States of America.ORCID 0000-0001-9575-3862
Rush University Medical Center · USUniversity of Gothenburg · SE

Funding

Detection and Treatment of Peri-Implant OsteolysisR01AR066562 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI SUMNER, D RICK · 2015 to 2019
$1.7M
Role of the Gut Microbiome in Implant LooseningR21AR075130 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI SUMNER, D RICK · 2019 to 2020
$380k
NIAMS NIH HHS R01 AR066562NIAMS NIH HHS R21 AR075130
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the intestinal tract and is associated with decreased bone mineral density. IBD patients are at higher risk of osteopenia, osteoporosis and fracture compared to non-IBD patients. The impact of IBD on the performance of orthopedic implants has not been well studied. We hypothesized that a history of IBD at the time of primary total hip arthroplasty (THA) would increase the risk of subsequent failure as assessed by revision surgery. A retrospective implant survival analysis was completed using the Swedish Hip Arthroplasty Registry and the Sweden National Patient Register. A total of 150,073 patients undergoing THA for osteoarthritis within an 18-year period were included in the study. THA patients with (n = 2,604) and without (n = 147,469) a history of IBD at the time of THA were compared with primary revision as the main endpoint and adjusted using sex, age category and comorbidity (Elixhauser scores) as covariates. We found that patients with a history of IBD had a relatively higher risk of revision surgery for septic causes while the non-IBD patients had a relatively higher risk of revision for aseptic causes (p = 0.004). Our findings suggest there may be an association between gut health and THA performance.

Indexed as

Bone DensityReoperationAgedAged, 80 and overAge FactorsArthroplasty, Replacement, HipBone Diseases, MetabolicFemaleHip ProsthesisHumansInflammatory Bowel DiseasesMaleMiddle AgedOsteoarthritisOsteoporosisProsthesis Failure

Identifiers

PMID34735461
PMCPMC8568118
OpenAlexW3210084204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.